Comparison of a Cortivazol (ALTIM®) Infiltration of Posterior Epidural Space at L3-L4 Stage Versus an Epidural Infiltration of Cortivazol (ALTIM®) on Contact With Disco Radicular Conflict in Discal Sciatica
EPI-AMELIE
1 other identifier
interventional
112
1 country
2
Brief Summary
In discal sciatica, after failure of medical treatment, the investigators propose frequently a spinal infiltration of corticoids the most closer of disco-radicular conflict. Recently, some cases of paraplegia during lumbar foraminal infiltrations have induce a reduction of indications of this type of infiltration. An alternative would be to propose a lateral epidural infiltration on contact with conflict.The objective of this study is to compare, in 112 patients with a less than 6 months discal sciatica, the efficacy on pain of a non target posterior epidural space infiltration of corticoids done at L3-L4 stage on scan control versus an epidural infiltration of the same corticoid done in lateral on contact of disco radicular conflict on scan control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Mar 2012
Longer than P75 for phase_3
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2012
CompletedFirst Submitted
Initial submission to the registry
May 28, 2014
CompletedFirst Posted
Study publicly available on registry
May 30, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2017
CompletedSeptember 1, 2015
August 1, 2015
5 years
May 28, 2014
August 31, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain evolution on analogic visual scale (EVA) ay Day 30
at Day 30 after infiltration
Secondary Outcomes (20)
Pain evolution on analogic visual scal (EVA) at Day 7
at day 7 after infiltration
Pain evolution on analogic visual scal (EVA) at month 3
at month 3 after infiltration
Pain evolution on analogic visual scal (EVA) at month 6
at month 6 after infiltration
Pain evolution on analogic visual scal (EVA) at month 12
at month 12 after infiltration
drug consumption at day 7
at day 7 after infiltration
- +15 more secondary outcomes
Study Arms (2)
Non target epidural infiltration at L3-L4 stage
ACTIVE COMPARATORIn this control arm, there are patients with a non target posterior epidural space infiltration of corticoids done at L3-L4 stage on scan control. These patients must have a discal hernia confirmed by scanner or RMI
Epidural infiltration on contact of disco radicular conflict
EXPERIMENTALIn this experimental arm, there are patients with an epidural infiltration of corticoids done in lateral on contact of disco radicular conflict on scan control. These patients must have a discal hernia confirmed by scanner or RMI
Interventions
For patients included in control arm, a non target posterior epidural space infiltration of corticoids will be done at L3-L4 stage on scan control
For patients included in experimental arm, an epidural infiltration of corticoids will be done in lateral on contact of disco radicular conflict on scan control.
Eligibility Criteria
You may qualify if:
- Informed consent
- Aged from 18 to 65 years
- Affiliated or benefit from an insurance regimen
- Patient with a sciatic answering to the definition
- Discal sciatica more than 15 days and less than 6 months
- Discal hernia (scan or RMI)
- Negative BHCG and normal coagulation parameters
You may not qualify if:
- History of lumbar surgery
- Iode allergy
- Anticoagulation therapy, unbalanced type 2 diabetes, instable HTA
- Motor loss \< 4 (muscular testing)
- Sphincter disorder (cauda equida syndrome)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
CHU de Montpellier - Hôpital Lapeyronie
Montpellier, 34295, France
CHU Carémeau
Nîmes, 30000, France
Study Officials
- PRINCIPAL INVESTIGATOR
Eric ET THOMAS, MD
CHU de Montpellier
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 28, 2014
First Posted
May 30, 2014
Study Start
March 1, 2012
Primary Completion
March 1, 2017
Study Completion
March 1, 2017
Last Updated
September 1, 2015
Record last verified: 2015-08